Strategies for AIDS vaccines

Area of Science:

• Immunology
• Vaccinology
• Epidemiology

Background:

• The global AIDS epidemic disproportionately affects young people, with millions of human immunodeficiency virus (HIV) infections projected to increase.
• A safe and effective HIV vaccine is crucial for controlling the epidemic, yet its development is complex.

Purpose of the Study:

• To review the progress and challenges in developing an effective vaccine against HIV.
• To explore various vaccine strategies, including inactivated, live attenuated, and subunit approaches.

Main Methods:

• Utilizing animal models, particularly simian immunodeficiency virus (SIV) infection in macaques, to study vaccine efficacy.
• Analyzing immune responses generated by different vaccine candidates in preclinical and clinical settings.

Main Results:

• Inactivated vaccines showed protection in models, but antibodies targeted cellular proteins, offering alternative strategies.
• Live attenuated vaccines, initially deemed hazardous, now show potent protection in models, prompting mechanistic studies.
• Subunit vaccines are safe and antigenic in humans, but induced antibodies show limited neutralization of circulating HIV strains.

Conclusions:

• Multiple vaccine approaches, including inactivated, live attenuated, and subunit vaccines, are under active investigation.
• Understanding mechanisms of protection from SIV models is key to developing safer and more effective HIV vaccines.
• Overcoming challenges in inducing durable and broadly neutralizing antibodies is critical for successful HIV vaccine development.